- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10.25 | AstraZeneca to invest $4.5bn in US manufacturing facility | ||
| 15.10.25 | Breast Cancer Awareness Month marked as London's King's Cross tunnel lights up in pink | ||
| 15.10.25 | Innovation, impact and the future: Communiqué Awards 2025 | ||
| 15.10.25 | Generative engine optimisation: closing AI gaps, creating market edge | ||
| 14.10.25 | La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars | ||
| 14.10.25 | Inizio announced as headline sponsor for 2026 Communiqué Awards | ||
| 14.10.25 | Bioxodes appoints Philippe Monteyne as new chairman of the board | ||
| 14.10.25 | Pre-commercial to launch-ready: four steps to sharpen strategy, execution and impact | ||
| 13.10.25 | David Weinreich appointed as Merck's head of R&D and CMO for healthcare | ||
| 13.10.25 | AstraZeneca announces agreement with US government to reduce medicine costs | ||
| 13.10.25 | Positioning with purpose | ||
| 10.10.25 | Lilly's Omvoh shows improved outcomes in ulcerative colitis | ||
| 10.10.25 | Ireland's largest cancer research initiative launches second phase | ||
| 10.10.25 | Epsilogen appoints Cristina Oliva as chief medical officer | ||
| 10.10.25 | Setting the direction - how exemplary brand teams brief their agency partners | ||
| 09.10.25 | MHRA and FDA expand collaboration on AI and medtech regulation | ||
| 09.10.25 | Lilly appoints former US FDA director Peter Marks to lead infectious disease division | ||
| 09.10.25 | Speak up to step forward | ||
| 08.10.25 | Pfizer's Lorviqua recommended by NICE for lung cancer | ||
| 08.10.25 | Prime welcomes James Karcher to senior leadership team | ||
| 08.10.25 | Driving launch excellence with agile transformation | ||
| 07.10.25 | Havas Life London appoints Fran Griffin as Head of Strategy | ||
| 07.10.25 | New study highlights global overuse of antibiotics for diverticulitis | ||
| 07.10.25 | The Rashomon Effect | ||
| 06.10.25 | PMLiVE's T40 - now open for submissions! |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .